In the breast carcinoma cell line MDA-MB-231, however, the agonistic antibodies C#16 and C#22 were, alone, less efficient, owing to the fact that this cell line is naturally resistant to TRAIL-induced apoptosis due to high expression levels of the caspase-8 inhibitor cFLIP34. Here, TNFSF10 is linked to breast carcinoma.